Commercial Cell and Gene Therapy Revenue -- $9.1 million, up 26% year over year, reflecting growth in therapies supported.

Independent biopharmaceutical company Specialised Therapeutics (ST) welcomes the approval of ZEPZELCA® (lurbinectedin), in combination with atezolizumab (Tecentriq®), as a new first-line maintenance ...

Single agent duvelisib demonstrated clinically meaningful response rates, including a substantial proportion of complete responses, in a heavily ...

Good day, ladies and gentlemen, and welcome to Repligen Corporation's First Quarter 2026 Earnings Conference Call. My name is Samantha, and I will be your coordinator. [Operator Instructions] I will ...

Following IDMC recommendation after interim futility analysis the decision was made to discontinue the TACTI-004 Phase III trialRoot cause ...

Focal segmental glomerulosclerosis (FSGS), a progressive kidney disease with an estimated global prevalence of 4%, occurs ...

Good morning, ladies and gentlemen. This is Marcus Poppe speaking. On behalf of Daimler Truck, I would like to welcome you to our Q1 results global conference call. We are very happy to have you with ...

Oh! How the tables have turned as Gordon Ramsay isn’t the one dishing out the critiques. One of the Michelin-starred The ...

Five additional pivotal trials for pumitamig initiated during 2026 in collaboration with Bristol Myers SquibbOncology pipeline strength and combination strategy highlighted through multiple clinical ...

Distrust and misinformation have made HMOs – houses in multiple occupation – an increasingly controversial topic ...

Battery-powered cleaners have many benefits, including the lack of hoses or cords and the ability to be removed from the ...

Ahead of the election, the Southern California News Group compiled a list of questions to pose to the candidates vying to ...